We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Futibatinib.
- Abstract
The article offers information on Futibatinib, a small molecule kinase inhibitor of fibroblast growth factor receptor (FGFR) 1, 2, 3, and 4. It presents the drug's uses including for the treatment of adult patients with intrahepatic cholangiocarcinoma. Also mentioned are its dosage and administration, drug interactions, and advice to patients.
- Subjects
RISK factors in miscarriages; RETINAL detachment -- Risk factors; THERAPEUTIC use of antineoplastic agents; HUMAN reproduction; PROTEIN kinase inhibitors; CHOLANGIOCARCINOMA; BREAST milk; WOMEN; PEDIATRICS; FETUS; DRUG labeling; GENE rearrangement; HYPERPHOSPHATEMIA; CALCINOSIS; DRUG interactions; HEALTH; INFORMATION resources; PHARMACY information services; ELDER care; DOSAGE forms of drugs; PHARMACODYNAMICS; DISEASE risk factors
- Publication
American Journal of Health-System Pharmacy, 2023, Vol 80, Issue 8, p470
- ISSN
1079-2082
- Publication type
Article
- DOI
10.1093/ajhp/zxad017